Mindbloom
vs. Joyous
Premium for a reason. While Joyous primarily offers ketamine prescriptions with minimal guidance, Mindbloom’s science-backed program goes beyond just medicine.
“I switched from Joyous to Mindbloom because the higher doses actually help me. "
The premium experience you can only get with Mindbloom.
When it comes to your mental health, cutting corners doesn’t cut it.
Joyous
Expertise
Peer-reviewed published studies
2
0
1:1 Coaching support
#1 Ketamine therapy provider in America
Treatment
Virtual clinician calls
2+
1
Not a daily pill
Injectables available
Support
Support availability
24/7
M–F,
9 AM–5 PM
Group Integration Circles
10+ Expert designed programs
Rewire your brain. Reclaim your life.
Purchase programMindbloom co-authored the two largest clinical studies on psychedelic therapy with over 10,000 participants.1,2
Joyous has not published any clinical trials to validate their protocols.
Research partners from:
Mindbloom changes lives.
But don’t just take our word for it.
Hear moving and mindful stories of personal transformation.*
*Opinions expressed belong to the individuals depicted. Results may vary and may not be representative of all clients. Individuals marked Paid Partner were compensated to share their experience.
Thomas D. Hull, Matteo Malgaroli, Adam Gazzaley, Teddy J. Akiki, Alok Madan, Leonardo Vando, Kristin Arden, Jack Swain, Madeline Klotz, Casey Paleos,At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial,Journal of Affective Disorders,Volume 314,2022,Pages 59-67,ISSN 0165-0327,https://doi.org/10.1016/j.jad.2022.07.004.
David S. Mathai, Thomas D. Hull, Leonardo Vando, Matteo Malgaroli, At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data,Journal of Affective Disorders,Volume 361,2024,Pages 198-208,ISSN 0165-0327,https://doi.org/10.1016/j.jad.2024.05.131.